Published in
Springer, Cancer Chemotherapy and Pharmacology, 4(86), p. 527-533, 2020
DOI: 10.1007/s00280-020-04133-w
Links
Tools
CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone
Journal article published in 2020 by
Stefania Crucitta,
Marzia Del Re 
,
Federico Paolieri,
Francesco Bloise,
Andrea Sbrana,
Enrico Sammarco ,
Chiara Mercinelli,
Federico Cucchiara ,
Lorenzo Fontanelli,
Luca Galli,
Romano Danesi
,
Federico Paolieri,
Francesco Bloise,
Andrea Sbrana,
Enrico Sammarco ,
Chiara Mercinelli,
Federico Cucchiara ,
Lorenzo Fontanelli,
Luca Galli,
Romano Danesi
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 